[1] 李伟, 安文军. 白蛋白联合特利加压素治疗肝肾综合征患者的临床疗效. 新疆医科大学学报, 2017, 40:1145-1148.
[2] 杨进山, 王宏旭. 多项血清生化指标检测在乙型肝炎后肝硬化诊断中的价值探讨. 中国实验诊断学, 2017, 21:1364-1366.
[3] 何流, 陈世银, 陈志富,等. 血清胱抑素c及其估算肾小球滤过率在亚临床肝肾综合征诊断中的应用. 现代生物医学进展, 2016, 16:6742-6745.
[4] Tayefi M, Tajfard M, Saffar S, et al. hs-CRP is strongly associated with coronary heart disease (CHD): A data mining approach using decision tree algorithm. Comput Methods Programs Biomed, 2017, 141:105-125.
[5] Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology, 2013, 57:1651-1653.
[6] 王艳景, 平骁功. 腹水超滤浓缩回输治疗肝硬化失代偿期合并顽固性肝腹水伴Ⅱ型肝肾综合征的临床效果. 中国地方病防治杂志, 2017,12:249-253.
[7] 董霞, 韩睿, 杨薇,等. 血浆CysC、Hcy、sICAM-1对糖尿病肾病早期检测的临床价值. 重庆医科大学学报, 2016,18:1142-1146.
[8] 严陈燕, 邬步云, 徐琳,等. 慢性肾脏病患者不同eGFR公式的结果差异研究. 中华肾脏病杂志, 2017, 33:249-257.
[9] 杨丽铃, 张倩, 吴琼,等. 甲基双加氧酶2在高糖刺激肾小球系膜细胞转化生长因子β1表达中的作用. 中华肾脏病杂志, 2016, 32:219-224.
[10] Hwang JC, Jiang MY, Lu YH, et al. Precedent fluctuation of serum hs-CRP to albumin ratios and mortality risk of clinically stable hemodialysis patients. PLoS One, 2015, 10:e0120266. |
